• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与种系DNA错配修复基因突变相关的癌症风险

Cancer risk associated with germline DNA mismatch repair gene mutations.

作者信息

Dunlop M G, Farrington S M, Carothers A D, Wyllie A H, Sharp L, Burn J, Liu B, Kinzler K W, Vogelstein B

机构信息

University of Edinburgh, Department of Surgery, Royal Infirmary, UK.

出版信息

Hum Mol Genet. 1997 Jan;6(1):105-10. doi: 10.1093/hmg/6.1.105.

DOI:10.1093/hmg/6.1.105
PMID:9002677
Abstract

The autosomal dominant syndrome of Hereditary Nonpolyposis Colorectal Cancer (HNPCC) is due to germline DNA mismatch repair gene mutations in most cases. However, the penetrance of such mutations outwith classical HNPCC kindreds is unknown because families studied to date have been specifically selected for research purposes. Using a population-based strategy, we have calculated the lifetime cancer risk associated with germline DNA mismatch repair gene mutations, irrespective of their family history. We identified 67 gene carriers whose risk to age 70 for all cancers was 91% for males and 69% for females. The risk of developing colorectal cancer was significantly greater for males than for females (74% versus 30%, P= 0.006). The risk of uterine cancer (42%) exceeded that for colorectal cancer in females, emphasising the need for uterine screening. Our findings give further insight into the biological effect of defective DNA mismatch repair. We have demonstrated a systematic approach to identifying individuals at high risk of cancer but who may not be part of classical HNPCC families. The risk estimates derived from these analyses provide a rational basis on which to guide genetic counselling and to tailor clinical surveillance.

摘要

遗传性非息肉病性结直肠癌(HNPCC)的常染色体显性综合征在大多数情况下是由种系DNA错配修复基因突变引起的。然而,由于迄今为止所研究的家族都是专门为研究目的而挑选的,所以此类突变在非典型HNPCC家族中的外显率尚不清楚。我们采用基于人群的策略,计算了与种系DNA错配修复基因突变相关的终生癌症风险,而不考虑其家族病史。我们识别出67名基因携带者,他们到70岁时患所有癌症的风险男性为91%,女性为69%。男性患结直肠癌的风险显著高于女性(74%对30%,P = 0.006)。女性患子宫癌的风险(42%)超过了结直肠癌,这凸显了子宫筛查的必要性。我们的研究结果进一步深入了解了有缺陷的DNA错配修复的生物学效应。我们展示了一种系统的方法来识别癌症高危个体,这些个体可能不属于典型的HNPCC家族。从这些分析中得出的风险估计为指导遗传咨询和定制临床监测提供了合理依据。

相似文献

1
Cancer risk associated with germline DNA mismatch repair gene mutations.与种系DNA错配修复基因突变相关的癌症风险
Hum Mol Genet. 1997 Jan;6(1):105-10. doi: 10.1093/hmg/6.1.105.
2
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.遗传性非息肉病性结直肠癌:诊断策略及其影响。
Evid Rep Technol Assess (Full Rep). 2007 May(150):1-180.
3
Microsatellite instability in early onset and familial colorectal cancer.早发性和家族性结直肠癌中的微卫星不稳定性
J Med Genet. 1996 Dec;33(12):981-5. doi: 10.1136/jmg.33.12.981.
4
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.阿姆斯特丹-I标准家族中无错配修复缺陷的癌症发病率较低:X型家族性结直肠癌
JAMA. 2005 Apr 27;293(16):1979-85. doi: 10.1001/jama.293.16.1979.
5
Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.在美国东部32个遗传性非息肉病性结直肠癌家系中基于基因组DNA的hMSH2和hMLH1突变筛查。
Cancer Res. 1997 Sep 1;57(17):3798-803.
6
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.林奇综合征(遗传性非息肉病性结直肠癌)的诊断
J Natl Cancer Inst. 2007 Feb 21;99(4):291-9. doi: 10.1093/jnci/djk051.
7
A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.在DNA错配修复正常的早发性结直肠癌或家族性结直肠癌中寻找种系APC突变。
Genes Chromosomes Cancer. 2001 Feb;30(2):181-6.
8
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.人源PMS1和人源PMS2在结直肠癌易感性中的作用。
Cancer Res. 2001 Nov 1;61(21):7798-802.
9
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.由于MSH6种系突变导致的非典型遗传性非息肉病性结直肠癌:对一个大型荷兰家系的分析。
J Med Genet. 2001 May;38(5):318-22. doi: 10.1136/jmg.38.5.318.
10
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.普通人群中的遗传性结直肠癌:从癌症登记到分子诊断。
Gut. 1999 Jul;45(1):32-8. doi: 10.1136/gut.45.1.32.

引用本文的文献

1
Early-stage endometrioid carcinoma with MSH6 protein deficiency: pitfalls in the diagnostic interpretation of microsatellite instability.伴有 MSH6 蛋白缺乏的早期子宫内膜样癌:微卫星不稳定性诊断解读中的陷阱
Front Oncol. 2025 May 21;15:1520500. doi: 10.3389/fonc.2025.1520500. eCollection 2025.
2
DNA Mismatch Repair Deficiency as a Biomarker in Sarcoma.DNA错配修复缺陷作为肉瘤的生物标志物
Surg Oncol Insight. 2024 Dec;1(4). doi: 10.1016/j.soi.2024.100091. Epub 2024 Aug 22.
3
Leveraging the power of long reads for targeted sequencing.
利用长读长片段进行靶向测序。
Genome Res. 2024 Nov 20;34(11):1701-1718. doi: 10.1101/gr.279168.124.
4
A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.一个受遗传性结直肠癌影响的家族中的母系生殖系突变体表型。
Genetics. 2024 Oct 15;228(4). doi: 10.1093/genetics/iyae166.
5
Colorectal Cancer and Asbestos Exposure: A Women's Health Perspective.结直肠癌与石棉暴露:女性健康视角
Healthcare (Basel). 2024 Sep 11;12(18):1816. doi: 10.3390/healthcare12181816.
6
Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.胃肠道恶性肿瘤:遗传与临床应用。
Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15.
7
Pancreatic Cancer: A Review of Risk Factors.胰腺癌:风险因素综述
Life (Basel). 2024 Aug 5;14(8):980. doi: 10.3390/life14080980.
8
[Gender-specific differences in the development of colorectal cancer in Lynch syndrome patients-A systematic review].[林奇综合征患者结直肠癌发生中的性别特异性差异——一项系统综述]
Chirurgie (Heidelb). 2024 Sep;95(9):696-708. doi: 10.1007/s00104-024-02159-x. Epub 2024 Aug 15.
9
Deciphering the dynamic code: DNA recognition by transcription factors in the ever-changing genome.解读动态密码:转录因子在不断变化的基因组中对DNA的识别
Transcription. 2024 Jun-Oct;15(3-5):114-138. doi: 10.1080/21541264.2024.2379161. Epub 2024 Jul 20.
10
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.林奇综合征:从多学科管理到精准预防
Cancers (Basel). 2024 Feb 20;16(5):849. doi: 10.3390/cancers16050849.